Skip to content

Understanding the disease process of young patients with a meniscal tear of the knee and response to treatment

The MEniscal TeaR Outcome (METRO) study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN11534691
Enrollment
200
Registered
2021-04-08
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presentation, treatment, and recovery for a meniscal tear of the knee Musculoskeletal Diseases

Interventions

Potential participants will be identified by attending clinical teams or clinical research teams by screening orthopaedic clinic lists e.g. fracture clinic, acute knee clinic or an elective knee clini

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Provision of written informed consent 2. Age 18 – 55 years 3. Presence of a MRI confirmed meniscal tear

Exclusion criteria

Exclusion criteria: 1. Anterior cruciate ligament or other major knee ligament injury. This does not include a previous unrelated healed medial collateral ligament tear or a meniscal root tear (which is considered a type of meniscal tear in this study) 2. Associated intra-articular fracture of the tibial plateau or femur. Previous fractures not thought to be related to the tear are not an exclusion criteria for the study 3. Previous knee surgery 4. Previous entry into the present study (i.e other knee) 5. Unable to provide informed consent or undertake study procedures

Design outcomes

Primary

MeasureTime frame
Meniscal tear disease-specific quality of life measured using the Western Ontario Meniscal Evaluation Tool (WOMET) at baseline, 3, 6 and 12 months

Secondary

MeasureTime frame
1. Knee injury impact on person measured using the Knee injury and Osteoarthritis outcome score 4 (KOOS) at baseline and 12 months 2. Quality of life measured using the EQ-5D-5L at baseline, 3, 6 and 12 months 3. Participant perception of improvement measured using the Patient global assessment of change (PGIC) at 3, 6 and 12 months 4. Surgery for the meniscal tear (yes/no) measured by self-report at 3, 6 and 12 months

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026